Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1711-2026

MEDLINE ANTERIOR HIP PACK DYNJ64672B Recall

MEDLINE ANTERIOR HIP PACK DYNJ64672B

FDA recall Class II

Ongoing

FDA lists this Class II recall for MEDLINE ANTERIOR HIP PACK DYNJ64672B. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1711-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Feb 16, 2026
FDA report date
Apr 8, 2026
Quantity in commerce
14,379 kits total
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

MEDLINE ANTERIOR HIP PACK DYNJ64672B

Affected model & UDI checker

Search the exact identifiers published for Z-1711-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedMEDLINE ANTERIOR HIP PACK DYNJ64672BCheck source notice10195327377496
Not specifiedMEDLINE ANTERIOR HIP PACK DYNJ64672BCheck source notice40195327377497
FDA code information

UDI-DI 10195327377496 (EA) 40195327377497 (CS) LOT 23LMD300

View the original FDA recall notice

Why was this product recalled?

Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Medline Industries, LP take?

Firm notified customers on 2/16/26. Consignees were provided with a copy of Olympus's notification, which includes reminders to follow the IFU. According to the firm, the component can continue to be utilized by the customer, along with the remainder of the kit.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology